Literature DB >> 20654687

Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling.

Pierre-Alexandre Vidi1, Karin F K Ejendal, Julie A Przybyla, Val J Watts.   

Abstract

G protein-coupled receptor (GPCR) signaling is mediated by protein-protein interactions at multiple levels. The characterization of the corresponding protein complexes is therefore paramount to the basic understanding of GPCR-mediated signal transduction. The number of documented interactions involving GPCRs is rapidly growing, and appreciating the functional significance of these complexes is clearly the next challenge. New experimental approaches including protein complementation assays (PCAs) have recently been used to examine the composition, plasma membrane targeting, and desensitization of protein complexes involved in GPCR signaling. These methods also hold promise for better understanding of drug-induced effects on GPCR interactions. This review focuses on the application of fluorescent PCAs for the study of GPCR signaling. Potential applications of PCAs in high-content screens are also presented. Non-fluorescent PCA techniques as well as combined assays for the detection of ternary and quaternary protein complexes are briefly discussed.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20654687      PMCID: PMC2990800          DOI: 10.1016/j.mce.2010.07.011

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  94 in total

1.  A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2.

Authors:  M A Davare; V Avdonin; D D Hall; E M Peden; A Burette; R J Weinberg; M C Horne; T Hoshi; J W Hell
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

2.  Dopamine D2 receptor dimer formation: evidence from ligand binding.

Authors:  D Armstrong; P G Strange
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

3.  Enzyme fragment complementation: a flexible high throughput screening assay technology.

Authors:  Richard M Eglen
Journal:  Assay Drug Dev Technol       Date:  2002-11       Impact factor: 1.738

4.  An improved cyan fluorescent protein variant useful for FRET.

Authors:  Mark A Rizzo; Gerald H Springer; Butch Granada; David W Piston
Journal:  Nat Biotechnol       Date:  2004-02-29       Impact factor: 54.908

5.  A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications.

Authors:  Takeharu Nagai; Keiji Ibata; Eun Sun Park; Mie Kubota; Katsuhiko Mikoshiba; Atsushi Miyawaki
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

6.  Dimerization of mammalian adenylate cyclases.

Authors:  Chen Gu; James J Cali; Dermot M F Cooper
Journal:  Eur J Biochem       Date:  2002-01

7.  Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell.

Authors:  S P Lee; B F O'Dowd; G Y Ng; G Varghese; H Akil; A Mansour; T Nguyen; S R George
Journal:  Mol Pharmacol       Date:  2000-07       Impact factor: 4.436

8.  Differentiation-induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line.

Authors:  Christopher A Johnston; Michael A Beazely; Matthew L Bilodeau; Ourania Andrisani; Val J Watts
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

9.  Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Authors:  Meritxell Canals; Javier Burgueño; Daniel Marcellino; Núria Cabello; Enric I Canela; Josefa Mallol; Luigi Agnati; Sergi Ferré; Michel Bouvier; Kjell Fuxe; Francisco Ciruela; Carmen Lluis; Rafael Franco
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

10.  D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.

Authors:  A Jarrahian; V J Watts; E L Barker
Journal:  J Pharmacol Exp Ther       Date:  2003-11-21       Impact factor: 4.030

View more
  7 in total

1.  PfSMAD1/5 Can Interact with PfSMAD4 to Inhibit PfMSX to Regulate Shell Biomineralization in Pinctada fucata martensii.

Authors:  Yu Shi; Mi Zhao; Maoxian He
Journal:  Mar Biotechnol (NY)       Date:  2020-01-20       Impact factor: 3.619

2.  Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes.

Authors:  Dasiel O Borroto-Escuela; Marc Flajolet; Luigi F Agnati; Paul Greengard; Kjell Fuxe
Journal:  Methods Cell Biol       Date:  2013       Impact factor: 1.441

3.  Application of in utero electroporation of G-protein coupled receptor (GPCR) genes, for subcellular localization of hardly identifiable GPCR in mouse cerebral cortex.

Authors:  Nam-Ho Kim; Seunghyuk Kim; Jae Seung Hong; Sung Ho Jeon; Sung-Oh Huh
Journal:  Mol Cells       Date:  2014-07-31       Impact factor: 5.034

Review 4.  Nucleic-Acid Driven Cooperative Bioassays Using Probe Proximity or Split-Probe Techniques.

Authors:  Andresa B Bezerra; Amanda S N Kurian; Christopher J Easley
Journal:  Anal Chem       Date:  2020-11-04       Impact factor: 6.986

5.  Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity.

Authors:  Sarah Norklit Roed; Anne Orgaard; Rasmus Jorgensen; Pierre De Meyts
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-07       Impact factor: 5.555

Review 6.  Oligomerization of Family B GPCRs: Exploration in Inter-Family Oligomer Formation.

Authors:  Hans K H Ng; Billy K C Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-02       Impact factor: 5.555

Review 7.  Methods used to study the oligomeric structure of G-protein-coupled receptors.

Authors:  Hui Guo; Su An; Richard Ward; Yang Yang; Ying Liu; Xiao-Xi Guo; Qian Hao; Tian-Rui Xu
Journal:  Biosci Rep       Date:  2017-04-20       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.